Advertisement

Topics

Search Results for "Dabur Sanat Pharma"

18:08 EST 14th February 2016 | BioPortfolio

Matching Channels

Datamonitor - aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapidly evolving marketplace

The Datamonitor Group aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapi...

Laboratory

Labs are the hub of much of modern medicine, either in the hospital setting processing patients blood tests and other samples, in research institutions at many universities or in the headquarters of...

OxyContin

OxyContin, an narcotic <!--LGfEGNT2Lhm-->analgesic produced by Purdue Pharma LP, nets $3m in <!--LGfEGNT2Lhm-->sales annually, placing it 8th in the world for annual sales. OxyContin i...

Eligard

Eligard® is a hormone compound for the treatment of advanced, hormone-dependent prostate cancer. The active ingredient (leuprolide acetate) significantly reduces the level of the male sex hormon...

Biosuperior Antibodies

After biosimilar versions of therapeutic proteins have become reality in Europe and in the US, now it’s the turn of therapeutic antibodies to be in the line of fire. Patents of the first wave of...

Matching News

NMT Pharma and CAO Pharma in licensing agreement for anti-cancer drug

Biospectrum NMT Pharma and CAO Pharma will enter into agreements that would secure funding needed by CAO Pharma to cont...

Forenap Pharma E.U.R.L. - Strategic SWOT Analysis Review

Recently added to the BioPortfolio report store, Forenap Pharma E.U.R.L. - Strategic SWOT Analysis Review is a new report from GlobalData published on 2015-09-11. This 15-page report is available in ...

VERONA PHARMA PLC - Board Changes

Verona Pharma plc ("Verona Pharma" or the "Company") Verona Pharma appoints Dr Ken Cunningham and Dr Anders Ullman as Non-Executive Directors 8 September 2015, Cardiff - Verona Pharma plc (AIM: VR...

Bal Pharma Limited (BALPHARMA) - Financial and Strategic SWOT Analysis Review

Recently added to the BioPortfolio report store, Bal Pharma Limited (BALPHARMA) - Financial and Strategic SWOT Analysis Review is a new report from GlobalData published on 2015-09-11. This 25-page re...

Horizon Pharma plc Sends Letter to Depomed, Inc Board of Directors / Horizon Pharma Stands by Its Proposal to Acquire All the Outstanding Shares of Depomed for $33.00 a Share in Horizon Pharma Stock, Assuming Parties Can Come to a Negotiated Agreement Qu

DUBLIN, IRELAND -- (Marketwired) -- 08/13/15 -- Horizon Pharma plc (NASDAQ: HZNP) ("Horizon Pharma"), a biopharmaceutical company focused on improving patients' lives by identifying, developing, a...

New York Pharma Forum explores ‘The Reinvention of Pharma’

David SalazarThe New York Pharma Forum’s 26th annual General Assembly featured a panel discussion and presentations from several experts in the global pharma industry. read more

B.M.P. Pharma Trading AG (BMP) - Financial and Strategic SWOT Analysis Review

Recently added to the BioPortfolio report store, B.M.P. Pharma Trading AG (BMP) - Financial and Strategic SWOT Analysis Review is a new report from GlobalData published on 2015-09-11. This 25-page re...

Moves in pharma app market, but user longevity an issue

Pharma companies continue to invest in the mobile app market, but studies have found that pharma apps suffer the same longevity challenges as programmes in the wider market. Amsterdam-based dermatolog...

Matching PubMed Articles

Digital health revolution: Perfect storm or perfect opportunity for pharmaceutical R&D?

The convergence of technology and medicine has pushed healthcare to the brink of a major disruption that pharma has, until recently, been slow to recognize. Tech players have pioneered the emerging fi...

Pharma Success in Product Development-Does Biotechnology Change the Paradigm in Product Development and Attrition.

The biotechnology segment of the overall biopharma industry has existed for only about 40-45 years, as a driver of new product development. This driving force was initiated with the FDA approval of r...

Management of osteoarthritis (OA) with the pharma-standard supplement FlexiQule (Boswellia): a 12-week registry.

This registry study assessed the pharma-standard supplement FlexiQule (Boswellia extract in capsules) in the management of symptoms associated to osteoarthritis (OA) also managed with the 'standard ma...

10 years after implementation of TRIPS obligations in India.

The Patent (Amendment) Act of 2005 enforced after TRIPS raises many issues which hinder growth of Indian pharma companies. To tackle this, Indian pharma companies doubled their R&D expenditure and bec...

Hepatoprotective activity of a new polyherbal formulation against paracetamol and D-galactosamine induced hepatic toxicity.

The present study was envisaged to evaluate the protective effect of polyherbal formulation, DRDC/AY/8060, developed by Dabur India Ltd., against paracetamol and D-galactosamine induced hepatic toxici...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement